1. Home
  2. DIT vs DBVT Comparison

DIT vs DBVT Comparison

Compare DIT & DBVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DIT
  • DBVT
  • Stock Information
  • Founded
  • DIT 1981
  • DBVT 2002
  • Country
  • DIT United States
  • DBVT France
  • Employees
  • DIT N/A
  • DBVT N/A
  • Industry
  • DIT Food Distributors
  • DBVT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • DIT Consumer Discretionary
  • DBVT Health Care
  • Exchange
  • DIT Nasdaq
  • DBVT Nasdaq
  • Market Cap
  • DIT 78.7M
  • DBVT 67.8M
  • IPO Year
  • DIT 1995
  • DBVT N/A
  • Fundamental
  • Price
  • DIT $135.00
  • DBVT $3.12
  • Analyst Decision
  • DIT
  • DBVT Strong Buy
  • Analyst Count
  • DIT 0
  • DBVT 2
  • Target Price
  • DIT N/A
  • DBVT $22.50
  • AVG Volume (30 Days)
  • DIT 212.0
  • DBVT 363.4K
  • Earning Date
  • DIT 01-16-2025
  • DBVT 11-06-2024
  • Dividend Yield
  • DIT 0.53%
  • DBVT N/A
  • EPS Growth
  • DIT N/A
  • DBVT N/A
  • EPS
  • DIT 7.15
  • DBVT N/A
  • Revenue
  • DIT $2,141,481,108.00
  • DBVT $12,515,000.00
  • Revenue This Year
  • DIT N/A
  • DBVT N/A
  • Revenue Next Year
  • DIT N/A
  • DBVT $2,860.00
  • P/E Ratio
  • DIT $19.03
  • DBVT N/A
  • Revenue Growth
  • DIT 8.41
  • DBVT 125.54
  • 52 Week Low
  • DIT $118.25
  • DBVT $0.44
  • 52 Week High
  • DIT $209.50
  • DBVT $4.50
  • Technical
  • Relative Strength Index (RSI)
  • DIT 46.90
  • DBVT 60.52
  • Support Level
  • DIT $134.43
  • DBVT $3.02
  • Resistance Level
  • DIT $149.00
  • DBVT $3.93
  • Average True Range (ATR)
  • DIT 5.67
  • DBVT 0.31
  • MACD
  • DIT -0.56
  • DBVT -0.06
  • Stochastic Oscillator
  • DIT 13.41
  • DBVT 6.76

About DIT AMCON Distributing Company

Amcon Distributing Co is engaged in the wholesale and retail distribution of consumer products such as cigarettes, tobacco, confectionery, health food, and others. It operates in two segments: Wholesale distribution segment distributing consumer products to the retail outlets including convenience stores, grocery stores, liquor stores, drug stores, and tobacco shops in the Central, Rocky Mountain, and Southern regions of the United States; and the Retail health food segment is a specialty retailer of natural/organic groceries and dietary supplements throughout the Midwest and Florida. The company earns a majority of the revenue from the Wholesale distribution segment.

About DBVT DBV Technologies S.A.

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Viaskin targets specific antigen-presenting immune cells in the skin, called Langerhans cells, that capture the antigen and migrate to the lymph node to activate the immune system without passage of the antigen into the bloodstream, minimizing systemic exposure in the body. Its main product candidate is Viaskin Peanut for the treatment of peanut-allergic patients.

Share on Social Networks: